The IEAG highlighted that these issues exacerbate existing operational and financial pressures faced by businesses operating at the ports. While acknowledging the FDA's crucial role in regulating products like food, drugs, and cosmetics, the association pointed out that delays in obtaining permits, which are integrated into the Integrated Customs Management System (ICUMS), disrupt the entire clearance chain.

Such prolonged delays can lead to substantial additional costs for importers, including terminal storage charges, demurrage, container detention fees, and increased financing expenses. The IEAG expressed concern that these escalating costs might ultimately be passed on to consumers in the form of higher prices.

The association is urging the FDA to investigate the root causes of these delays, whether technical, operational, or administrative, and to restore normal processing times for compliant applications. They also called for expedited handling of pending applications for goods already at the port and accruing charges, and for clear communication regarding the challenges and expected resolution timelines.